A drug discovery venture pioneering novel cancer therapies through innovative technologies.
Challenging unmet medical needs with new drug development
Our vision
Revolutionizing healthcare, treatment methodologies, and economic rationality through groundbreaking research and exploratory studies, transcending conventional wisdom to embark on a new era.
Mission statement
Creating or discovering innovative anti-cancer drugs through industry-academia collaboration, ensuring a high quality of life (QOL) for patients post-treatment, free from anxiety. We aim to contribute to a society that can adapt to societal changes by improving healthy life expectancy.
Value
- Approaching all cancer treatments with a fresh perspective, unconstrained by existing concepts.
- Challenge areas where treatment is prolonged, rather than solely focusing on market size.
- Contributing to reducing the burden on patients through cost-effective therapies.
- Leaping to a new dimension in cancer treatment with novel ideas and perspectives.
News
- 2025-04-30NewsHOIST Corporation announces the publication of a novel method to generate patient-derived xenograft (PDX) models from cryopreserved cancer tissues
- 2025-03-27NewsAnnouncement Regarding Appointment of Representative Director
- 2025-03-21NewsHOIST Corporation announces a poster presentation at SOT 2025 regarding HM-001, currently in clinical studies
- 2025-02-18NewsNotice regarding the resignation of a representative director
- 2025-01-06NewsPublication regarding an efficient preparation method of Patient Derived Xenografts (PDX)
Message
Founder's Message
Former Professor Kazutake Tsujikawa,
Graduate School of Pharmaceutical Sciences, The University of Osaka
Graduate School of Pharmaceutical Sciences, The University of Osaka
Access
Headquarters
Headquarters:New Erimo Building 8F (A-2),
2-2-1 Senbanishi, Minoh, Osaka 562-0036, Japan
2-2-1 Senbanishi, Minoh, Osaka 562-0036, Japan
Wakayama Medical University Collaborative Research Laboratory
811-1 Kimiidera, Wakayama, Wakayama 641-8509, Japan
Center for Next-Generation Medicine Research, 401, Kimiidera Campus, Wakayama Medical University
Center for Next-Generation Medicine Research, 401, Kimiidera Campus, Wakayama Medical University